JP2010538040A5 - - Google Patents

Download PDF

Info

Publication number
JP2010538040A5
JP2010538040A5 JP2010523500A JP2010523500A JP2010538040A5 JP 2010538040 A5 JP2010538040 A5 JP 2010538040A5 JP 2010523500 A JP2010523500 A JP 2010523500A JP 2010523500 A JP2010523500 A JP 2010523500A JP 2010538040 A5 JP2010538040 A5 JP 2010538040A5
Authority
JP
Japan
Prior art keywords
alkyl
methyl
amino
phenylsulfonyl
phosphonic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010523500A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010538040A (ja
Filing date
Publication date
Priority claimed from DE102007042154A external-priority patent/DE102007042154A1/de
Application filed filed Critical
Publication of JP2010538040A publication Critical patent/JP2010538040A/ja
Publication of JP2010538040A5 publication Critical patent/JP2010538040A5/ja
Pending legal-status Critical Current

Links

JP2010523500A 2007-09-05 2008-09-04 アリールスルホニルアミノメチルホスホン酸誘導体、その製法及びその医薬組成物としての使用 Pending JP2010538040A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102007042154A DE102007042154A1 (de) 2007-09-05 2007-09-05 Arylsulfonylaminomethyphosphonsäure-Derivate, deren Herstellung und deren Verwendung als Arzneimittel
PCT/EP2008/061651 WO2009030715A1 (en) 2007-09-05 2008-09-04 Arylsulfonylaminomethylphosphonic acid derivatives, the preparation thereof and the use thereof as pharmaceutical compositions

Publications (2)

Publication Number Publication Date
JP2010538040A JP2010538040A (ja) 2010-12-09
JP2010538040A5 true JP2010538040A5 (enExample) 2011-09-29

Family

ID=39967609

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010523500A Pending JP2010538040A (ja) 2007-09-05 2008-09-04 アリールスルホニルアミノメチルホスホン酸誘導体、その製法及びその医薬組成物としての使用

Country Status (6)

Country Link
US (1) US8163911B2 (enExample)
EP (1) EP2200987A1 (enExample)
JP (1) JP2010538040A (enExample)
CA (1) CA2698486A1 (enExample)
DE (1) DE102007042154A1 (enExample)
WO (1) WO2009030715A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007012284A1 (de) 2007-03-16 2008-09-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel
DE102007035334A1 (de) 2007-07-27 2009-01-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel
DE102007035333A1 (de) 2007-07-27 2009-01-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel
DE102007042154A1 (de) 2007-09-05 2009-03-12 Boehringer Ingelheim Pharma Gmbh & Co. Kg Arylsulfonylaminomethyphosphonsäure-Derivate, deren Herstellung und deren Verwendung als Arzneimittel
DE102008019838A1 (de) * 2008-04-19 2009-12-10 Boehringer Ingelheim International Gmbh Neue Arylsulfonylglycin-Derivate, deren Herstellung und deren Verwendung als Arzneimittel
WO2011107494A1 (de) 2010-03-03 2011-09-09 Sanofi Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201215387A (en) 2010-07-05 2012-04-16 Sanofi Aventis Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
TW201221505A (en) 2010-07-05 2012-06-01 Sanofi Sa Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
TW201215388A (en) 2010-07-05 2012-04-16 Sanofi Sa (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
WO2013037390A1 (en) 2011-09-12 2013-03-21 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
EP2567959B1 (en) 2011-09-12 2014-04-16 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
EP2760862B1 (en) 2011-09-27 2015-10-21 Sanofi 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
US9326295B1 (en) 2014-12-10 2016-04-26 Sony Corporation Method and apparatus for transmitting a-priori information in a communication system

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2759228B2 (ja) 1992-05-21 1998-05-28 株式会社大塚製薬工場 ホスホン酸ジエステル誘導体
TW260664B (enExample) 1993-02-15 1995-10-21 Otsuka Pharma Factory Inc
DE19753522A1 (de) 1997-12-03 1999-06-10 Boehringer Ingelheim Pharma Substituierte Indole, ihre Herstellung und ihre Verwendung als Arzneimittel
US6312662B1 (en) 1998-03-06 2001-11-06 Metabasis Therapeutics, Inc. Prodrugs phosphorus-containing compounds
JP2000247949A (ja) 1999-02-26 2000-09-12 Eisai Co Ltd スルホンアミド含有インドール化合物
GB9926302D0 (en) * 1999-11-05 2000-01-12 Smithkline Beecham Plc Novel compounds
US6498151B2 (en) 2000-03-22 2002-12-24 Merck Frosst Canada & Co. Aryldifluoromethylphosphonic acids with sulfur-containing substituents as PTP-1B inhibitors
GB0110797D0 (en) * 2001-05-02 2001-06-27 Celltech R&D Ltd Chemical compounds
PE20021091A1 (es) 2001-05-25 2003-02-04 Aventis Pharma Gmbh Derivados de fenilurea sustituidos con carbonamida y procedimiento para su preparacion
DE10215907A1 (de) 2002-04-11 2003-11-06 Aventis Pharma Gmbh Acyl-4-carboxyphenyl-harnstoffderivate, Verfahren zu deren Herstellung und deren Verwendung
US7223796B2 (en) 2002-04-11 2007-05-29 Sanofi-Aventis Deutschland Gmbh Acyl-4-carboxyphenylurea derivatives, processes for preparing them and their use
DE50311923D1 (de) 2002-07-11 2009-10-29 Sanofi Aventis Deutschland Harnstoff- und urethan-substituierte acylharnstoffe, verfahren zu deren herstellung und deren verwendung als arzneimittel
US7262220B2 (en) 2002-07-11 2007-08-28 Sanofi-Aventis Deutschland Gmbh Urea- and urethane-substituted acylureas, process for their preparation and their use
AU2003249937A1 (en) 2002-07-12 2004-02-02 Sanofi-Aventis Deutschland Gmbh Heterocyclically substituted benzoylureas, method for their production and their use as medicaments
EP1636224B1 (en) 2003-05-21 2010-07-14 Prosidion Limited Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phoshorylase
ES2222827B1 (es) 2003-07-30 2006-03-01 Laboratorios Del Dr. Esteve, S.A. Derivados de 5-indolilsulfonamidas, su preparacion y su aplicacion como medicamentos.
ES2222832B1 (es) 2003-07-30 2006-02-16 Laboratorios Del Dr. Esteve, S.A. Derivados de 6-indolilsulfonamidas, su preparacion y su aplicacion como medicamentos.
ES2222829B1 (es) 2003-07-30 2006-03-01 Laboratorios Del Dr. Esteve, S.A. Derivados de 4-indolilsulfonamidas, su preparacion y su aplicacion como medicamentos.
EP1513085A1 (en) 2003-09-08 2005-03-09 Abb Research Ltd. Method of scheduling maintenance actions
JP2005206492A (ja) 2004-01-21 2005-08-04 Sankyo Co Ltd スルホンアミド化合物
KR20070115865A (ko) 2004-09-21 2007-12-06 아더시스 인코포레이티드 Crth2 수용체 길항작용을 나타내는 벤즈이미다졸아세트산 및 이의 용도
NZ554783A (en) * 2004-11-15 2010-12-24 Ceptyr Inc Protein tyrosine phosphatase inhibitors and methods of use thereof
HRP20140975T1 (hr) * 2005-10-07 2014-11-21 Exelixis, Inc. Derivati n-(3-amino-hinoksalin-2-il)-sulfonamida i njihova uporaba kao inhibitora fosfatidilinozitol 3-kinaze
DE102007007751A1 (de) 2007-02-16 2008-08-21 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel
WO2008103354A2 (en) 2007-02-20 2008-08-28 Cropsolution, Inc. Modulators of acetyl-coenzyme a carboxylase and methods of use thereof
DE102007012284A1 (de) 2007-03-16 2008-09-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel
DE102007035333A1 (de) 2007-07-27 2009-01-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel
DE102007035334A1 (de) 2007-07-27 2009-01-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel
DE102007042154A1 (de) 2007-09-05 2009-03-12 Boehringer Ingelheim Pharma Gmbh & Co. Kg Arylsulfonylaminomethyphosphonsäure-Derivate, deren Herstellung und deren Verwendung als Arzneimittel

Similar Documents

Publication Publication Date Title
AU2010224245B2 (en) Pyrrolo [2, 3-b] pyridine derivatives for the inhibition of Raf kinases
EP2458996B1 (en) Novel oral forms of a phosphonic acid derivative
AU2012279332B2 (en) Compounds for the treatment of addiction
ES2929906T3 (es) Derivado de 2,3-dihidro-isoindol-1-ona como supresor de cinasa BTK, y composición farmacéutica que lo incluye
SG175810A1 (en) Pyrrolo [2, 3. b] pyridines which inhibit raf protein kinase
CN105085483B (zh) 激酶抑制剂及其应用
JP2006524662A5 (enExample)
EP2406260A1 (en) Pyrrolo [2, 3-b]pyridine derivatives for the inhibition of raf kinases
CN1027507C (zh) 新的磺酰化合物的制备方法
KR20130099064A (ko) (아자)인돌리진 유도체 및 그 의약용도
CA2698486A1 (en) Arylsulfonylaminomethylphosphonic acid derivatives, the preparation thereof and the use thereof as pharmaceutical compositions
CN102497866B (zh) 含有噁唑烷酮的二聚体化合物、组合物以及制备方法和用途
CN103842353A (zh) 作为激酶抑制剂的吡啶化合物
EP4010330A1 (en) Quinoline derivatives as protein kinase inhibitors
CN102186824B (zh) 稠环衍生物及其医药用途
WO2021164538A1 (zh) 一种多靶点酪氨酸激酶抑制剂
JP2009539889A (ja) スピロシクロピペラジン類の第四級アンモニウム塩化合物、その製造方法および使用
CN103183709B (zh) 一种米诺膦酸新晶型及其制备方法和用途
KR102046196B1 (ko) 이미다조피리딘 유도체의 치료적 용도
JP3459407B2 (ja) 安定剤としてグリシンを含む製薬学的製剤
WO2026096860A1 (en) Tshr inhibitors and methods of use thereof
CN105399719A (zh) 一种伪麻黄碱类衍生物及其抗胃肠溃疡应用
CN105440016A (zh) 吲哚、氮杂吲哚类衍生物、其制备方法及其在医药上的应用
BR112020003557B1 (pt) Formas cristalinas de um composto de triaminopirimidina, processos para a preparação do referido composto, composto de triaminopirimidina apresentando as referidas formas cristalinas e composições compreendendo o referido composto
WO2019223672A1 (zh) 用于治疗非小细胞肺癌的喹啉衍生物